Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans (Q39290828)

10 September 2017

Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans (English)

1 reference

Japanese encephalitis virus

10 September 2017

0 references

attenuated vaccine

1 reference

inferred from title

Japanese encephalitis

1 reference

Japanese encephalitis vaccine

inferred from title

1 reference

1 reference

4

Sang-Im Yun

1 reference

10 September 2017

Byung-Hak Song

1

1 reference

10 September 2017

Gil-Nam Yun

series ordinal

2

1 reference

10 September 2017

Jin-Kyoung Kim

series ordinal

3

1 reference

10 September 2017

Young-Min Lee

series ordinal

5

1 reference

10 September 2017

25 August 2012

1 reference

The Journal of Microbiology

10 September 2017

1 reference

10 September 2017

50

1 reference

10 September 2017

4

1 reference

10 September 2017

698-706

1 reference

https://scigraph.springernature.com/pub.10.1007/s12275-012-2336-6

10 September 2017

0 references

cites work

De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Current use and development of vaccines for Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

The molecular biology of West Nile Virus: a new invader of the western hemisphere

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Taxonomy of the virus family Flaviviridae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Estimated global incidence of Japanese encephalitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Flavivirus genome organization, expression, and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Mechanisms of evasion of the type I interferon antiviral response by flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Past, Present, and Future of Japanese Encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

West Nile virus inhibits the signal transduction pathway of alpha interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Japanese encephalitis: new options for active immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

New Japanese encephalitis vaccines: alternatives to production in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

21 January 2018

Viral membrane fusion

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Comparison of replication rates and pathogenicities between the SA14 parent and SA14-14-2 vaccine strains of Japanese encephalitis virus in mouse brain neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Detection of west Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Japanese encephalitis vaccine in travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Ixiaro: a new vaccine against Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

A Single N-Linked Glycosylation Site in the Japanese Encephalitis Virus prM Protein Is Critical for Cell Type-Specific prM Protein Biogenesis, Virus Particle Release, and Pathogenicity in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

IC51 Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Mutations in the Yellow Fever Virus Nonstructural Protein NS2A Selectively Block Production of Infectious Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Role of Nonstructural Protein NS2A in Flavivirus Assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Molecular biology of flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Molecular and Functional Analyses of Kunjin Virus Infectious cDNA Clones Demonstrate the Essential Roles for NS2A in Virus Assembly and for a Nonconservative Residue in NS3 in RNA Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

5'- and 3'-noncoding regions in flavivirus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-hu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Structure of West Nile Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

A structural perspective of the flavivirus life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Inhibition of interferon signaling by dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Comparison of nucleotide and deduced amino acid sequence of the 5' non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Control of dengue virus translation and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Yellow Fever Virus NS3 Plays an Essential Role in Virus Assembly Independent of Its Known Enzymatic Functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Outbreak of Japanese encephalitis on the island of Saipan, 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Translation of the Flavivirus Kunjin NS3 Gene in cis but Not Its RNA Sequence or Secondary Structure Is Essential for Efficient RNA Packaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Allergic reactions to Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

West Nile Virus 5'-Cap Structure Is Formed by Sequential Guanine N-7 and Ribose 2'-O Methylations by Nonstructural Protein 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

The natural history of Japanese encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese encephalitis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Control of Japanese encephalitis--within our grasp?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Complete nucleotide sequence of the Japanese encephalitis virus genome RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Ecology and geographical expansion of Japanese encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Genome cyclization as strategy for flavivirus RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Transmission cycles, host range, evolution and emergence of arboviral disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Present and future arboviral threats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

The carboxy-terminal part of the NS 3 protein of the West Nile Flavivirus can be isolated as a soluble protein after proteolytic cleavage and represents an RNA-stimulated NTPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

The NS 3 nonstructural protein of flaviviruses contains an RNA triphosphatase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Japanese encephalitis: update on vaccines and vaccine recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Molecular characterization of the full-length genome of the Japanese encephalitis viral strain K87P39.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Development and Application of a Reverse Genetics System for Japanese Encephalitis Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Visualization of membrane protein domains by cryo-electron microscopy of dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-012-2336-6

Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties

21 January 2018

1 reference

12 December 2020

The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids

1 reference

12 December 2020

Japanese encephalitis in north Queensland, Australia, 1998.

1 reference

12 December 2020

Replication and gene function in Kunjin virus

1 reference

12 December 2020

Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis

1 reference

12 December 2020

Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

12 December 2020

Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity

1 reference

12 December 2020

A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses

1 reference

12 December 2020

Global Advisory Committee on Vaccine Safety, 12-13 December 2007

1 reference

12 December 2020

Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children

1 reference

12 December 2020

Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites

1 reference

12 December 2020

Japanese encephalitis as an emerging virus: the emergence and spread of Japanese encephalitis virus in Australasia.

1 reference

12 December 2020

Japanese encephalitis vaccines

1 reference

12 December 2020

Neurovirulence and host factors in flavivirus encephalitis--evidence from clinical epidemiology

1 reference

12 December 2020

Japanese encephalitis virus: ecology and epidemiology.

1 reference

12 December 2020

Japanese encephalitis vaccines: current vaccines and future prospects

1 reference

12 December 2020

An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995.

1 reference

12 December 2020

Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com

1 reference

12 December 2020

The Japanese encephalitis serological group of flaviviruses: a brief introduction to the group.

1 reference

12 December 2020

Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine--a comparison of 1- and 3-month immunization schedules

1 reference

12 December 2020

Global Advisory Committee on Vaccine Safety, 9-10 June 2005

1 reference

12 December 2020

Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study

1 reference

12 December 2020

Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.

1 reference

12 December 2020

Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections.

1 reference

12 December 2020

10.1007/S12275-012-2336-6

Identifiers

DOI

1 reference

release_b6kxdemrjzegldgwlwl7boyof4

10 September 2017

0 references

1 reference